ANZ News
Also, University of Queensland research has found ultrasound to be a safe approach to possibly treat symptoms of Alzheimer's disease in a world's first in-human trial.
AeviceMD says it has yet to conduct pilot deployments, which would focus on incorporating respiratory monitoring into outpatient asthma management pathways.
The Australian research, which aims to help people with motor neuron disease keep moving, is now testing AI to personalise assistance.
Screening rates in northern Queensland lag behind the statewide average.
The model can also make zero-shot predictions.
It demonstrated over 90% accuracy in detecting binary foetal movements in a hospital trial.
After setting up a 24/7 digital GP front door, the New Zealand government has provided funding for a new online platform to access mental health services.
Developed by Cancer Institute NSW, the multi-data-trained tool aims to educate people over 40 about their cancer risks.
Also, Topcon acquires New Zealand-founded Toku to expand access to AI-based health screening using retinal images.
Back2U connects patients to nearby certified practitioners in minutes using a custom geolocation engine.